Children (Feb 2023)

Neuropsychological Outcomes of Children Treated for Brain Tumors

  • Alessia Pancaldi,
  • Marisa Pugliese,
  • Camilla Migliozzi,
  • Johanna Blom,
  • Monica Cellini,
  • Lorenzo Iughetti

DOI
https://doi.org/10.3390/children10030472
Journal volume & issue
Vol. 10, no. 3
p. 472

Abstract

Read online

Central nervous system (CNS) neoplasms are the most common solid tumors diagnosed in children. CNS tumors represent the leading cause of cancer death and cancer-related morbidity for children less than 20 years of age, although there has been a moderate increase in survival rates over the past several decades. The average survival at 5 years now nearly reaches 75%, and for some, non-malignant histology approximates 97% at 20 years from diagnosis. Neurological, cognitive, and neuropsychological deficits are the most disabling long-term effects of brain tumors in children. Childhood is a time of extreme brain sensitivity and the time of life in which most brain development occurs. Thus, the long-term toxicities that children treated for CNS tumors experience can affect multiple developmental domains and day-to-day functioning, ultimately leading to a poor quality of survival (QoS). We reviewed literature focusing on the risk factors for cognitive and neuropsychological impairment in pediatric patients treated for brain tumors with the aim of better understanding who is at major risk and what the best strategies for monitoring these patients are.

Keywords